Premium
Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first‐line therapy (KDOG0201 Study)
Author(s) -
Koizumi W.,
Tanabe S.,
Nakatani K.,
Ishido K.,
Nishimura K.,
Azuma M.,
Ae T.,
Sasaki T.,
Higuchi K.,
Katada C.,
Nakayama N.,
Saigenji K.
Publication year - 2010
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/j.1365-2710.2009.01092.x
Subject(s) - metronidazole , clarithromycin , omeprazole , helicobacter pylori , amoxicillin , medicine , gastroenterology , breath test , urea breath test , peptic , antibiotics , peptic ulcer , helicobacter pylori infection , microbiology and biotechnology , biology
Summary Background and object: An antiulcer agent, ecabet sodium, is active against Helicobacter pylori . The aim of the present study was to clinically examine whether eradication therapy, which includes ecabet sodium, is effective in eradication of H. pylori after failure of first‐line therapy. Methods: Patients with peptic ulcer who failed with first‐line triple eradication therapy containing clarithromycin received quadruple therapy with omeprazole (20 mg, twice daily), amoxicillin (750 mg, twice daily), metronidazole (500 mg, twice daily) and ecabet sodium (1000 mg, twice daily) for 14 days. Eradication of H. pylori was judged by 13 C‐urea breath test 8 weeks later. Results: Fifty‐two patients (36 men and 16 women) were included. Their mean age was 51·4 years (range 28–73). One patient dropped out because of diarrhoea. The eradication rate was 98·0% (50/51) according to the per‐protocol analysis and 96·2% (50/52) according to the intention‐to‐treat analysis. Side effects occurred in seven patients, but none were serious. Conclusions: Quadruple therapy including ecabet sodium is useful as second‐line eradication treatment for H. pylori .